ANTHEM BIOSCIENCES
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of Anthem Biosciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
1.13₹ 7.00
As on Jan 13, 2026, 4:01 PM IST
Anthem Biosciences Price Performance
Today's LowToday's High
₹612.00₹631.20
₹624.60
52 Weeks' Low52 Weeks' High
₹602.85₹873.25
₹624.60
Open Price
₹618.00
Prev. Close
₹617.60
Volume
7,308
Over the last 5 years, the share price of Anthem Biosciences has declined 3.08% CAGR. Over the past year, the corresponding return has been -14.48%.
Anthem Biosciences’s current P/E of 67.96x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Anthem Biosciences Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Anthem Biosciences | -4.74 | -10.62 | -19.14 | -14.48 | -14.48 | -5.08 | -3.08 |
| Sun Pharmaceutical Industries | -2.96 | -3.75 | 4.58 | 2.84 | -2.20 | 18.84 | 23.50 |
| Divi's Laboratories | -3.14 | 1.37 | -1.91 | -5.15 | 7.27 | 24.28 | 11.57 |
| Torrent Pharmaceuticals | -3.70 | 4.21 | 11.96 | 15.64 | 21.07 | 36.43 | 23.28 |
| Cipla | -1.31 | -3.92 | -6.76 | -2.46 | 0.01 | 10.67 | 11.47 |
| Dr. Reddy's Laboratories | -4.20 | -7.03 | -3.79 | -4.84 | -10.99 | 11.24 | 2.38 |
| Lupin | -1.94 | 3.85 | 12.03 | 12.78 | 0.72 | 42.16 | 15.25 |
| Mankind Pharma | -4.44 | 3.08 | -9.32 | -18.18 | -17.31 | 15.76 | 9.18 |
| Zydus Lifesciences | -3.01 | -2.39 | -8.16 | -7.15 | -10.15 | 26.78 | 13.06 |
| Alkem Laboratories | 1.28 | 4.42 | 6.72 | 21.15 | 11.23 | 24.64 | 13.69 |
| Aurobindo Pharma | -6.17 | -2.23 | 3.17 | 1.78 | -1.34 | 38.62 | 4.12 |
| Abbott India | -1.21 | 0.91 | -6.49 | -18.14 | -0.37 | 8.14 | 13.40 |
| Laurus Labs | -6.33 | 5.27 | 20.61 | 28.27 | 86.04 | 43.60 | 24.88 |
| Biocon | -2.84 | -3.67 | 6.95 | -0.79 | -2.97 | 14.27 | -4.07 |
| Glenmark Pharmaceuticals | -5.28 | 0.82 | 5.69 | -9.77 | 32.12 | 68.24 | 31.26 |
| GlaxoSmithKline Pharmaceuticals | -3.11 | -7.52 | -13.82 | -25.28 | 14.64 | 22.11 | 9.26 |
| Ipca Laboratories | -0.71 | 4.27 | 15.23 | 3.14 | -5.37 | 19.98 | 7.48 |
| Ajanta Pharma | -4.40 | 3.36 | 14.01 | 2.98 | -3.10 | 32.30 | 18.16 |
| Emcure Pharmaceuticals | 1.38 | 10.88 | 15.60 | 14.27 | 14.59 | 4.45 | 2.65 |
| J B Chemicals & Pharmaceuticals | -3.68 | 3.97 | 12.43 | 13.63 | 5.84 | 23.95 | 28.69 |
Over the last one year, Anthem Biosciences has declined 14.48% compared to peers like Sun Pharmaceutical Industries (-2.20%), Divi's Laboratories (7.27%), Torrent Pharmaceuticals (21.07%). From a 5 year perspective, Anthem Biosciences has underperformed peers relative to Sun Pharmaceutical Industries (23.50%) and Divi's Laboratories (11.57%).
Anthem Biosciences Financials
Anthem Biosciences Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 637.91 | 632.07 |
| 10 | 642.17 | 639.18 |
| 20 | 656.03 | 647.84 |
| 50 | 662.29 | 669.85 |
| 100 | 728.68 | 715.7 |
| 200 | 439.89 | 0 |
Anthem Biosciences Share Holding Pattern
In the latest quarter, Anthem Biosciences remained same as its previous close in promoter holding, while DII stake increased to 7.21%, FII holding rose to 1.66%, and public shareholding moved down to 16.42% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Anthem Biosciences Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 36,82,926 | 0.77 | 233.76 | |
| 31,99,705 | 2.43 | 203.09 | |
| 27,25,524 | 0.99 | 172.99 | |
| 25,27,058 | 1.28 | 160.39 | |
| 17,00,000 | 1.8 | 107.9 | |
| 14,40,566 | 0.26 | 91.43 | |
| 13,35,040 | 2.89 | 84.74 | |
| 13,00,000 | 2 | 82.51 | |
| 11,07,065 | 1.65 | 70.27 | |
| 10,58,503 | 0.79 | 67.18 |
* Excluding Index & Arbitrage Funds
Anthem Biosciences Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 07, 2026, 9:57 PM IST | Anthem Biosciences - Compliance Certificate Under Regulation 74(5) Of SEBI (DP) Regulations, 2018 |
| Jan 07, 2026, 7:48 PM IST | Anthem Biosciences - Intimation Under Regulation 30 Of SEBI LODR Regulations With Reference To Issuance Of Corporate Guarante |
| Dec 15, 2025, 8:37 PM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Nov 12, 2025, 11:49 PM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 11, 2025, 5:51 AM IST | Anthem Biosciences - Intimation Of Violation Under Company'S Code Of Conduct To Regulate, Monitor And Report Trading By Desig |
About Anthem Biosciences
Anthem Biosciences Ltd. is a Public Limited Listed company incorporated on 13/06/2006 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is U24233KA2006PLC039703 and registration number is 039703. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 1840.65 Cr. and Equity Capital is Rs. 111.82 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressNo. 49, F1 & F2, Canara Bank Road, Bommasandra Industrial Area, Phase 1, Bommasandra, Bengaluru Karnataka 560099
- Contact
Management
- Mr. Ajay BhardwajChairman & M.D & CEO
- Mr. Ganesh SambasivamWhole Time Director
- Mr. K Ravindra ChandrappaWhole Time Director
- Mr. Satish Chander SubbannaNon Exe. & Nominee Director
- Mr. Ramesh RamaduraiInd. Non-Executive Director
- Mr. Ravikant UppalInd. Non-Executive Director
- Mr. Subramanian MadhavanInd. Non-Executive Director
- Ms. Shubha KulkarniInd. Non-Executive Director
FAQs on Anthem Biosciences Share Price
What is the share price of Anthem Biosciences?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Anthem Biosciences is ₹624.60 as on Jan 13, 2026.
What kind of stock is Anthem Biosciences?
The Anthem Biosciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Anthem Biosciences?
The market cap of Anthem Biosciences is ₹35,078.16 Cr as on Jan 13, 2026.
What are today's High and Low prices of Anthem Biosciences?
Today’s highest and lowest price of Anthem Biosciences are ₹631.20 and ₹612.00.
What are the 52 Week High and 52 Week Low of Anthem Biosciences?
The 52-week high/low is the highest and lowest price at which Anthem Biosciences stock has traded in the past 52-week or nearly a year. The 52-week high of Anthem Biosciences is ₹873.25 and 52-week low of Anthem Biosciences is ₹602.85 as on Jan 13, 2026.
How has the Anthem Biosciences performed historically in terms of returns?
The Anthem Biosciences has shown returns of 1.13% over the past day, -10.62% for the past month, -20.41% over 3 months, -14.48% over 1 year, -5.08% across 3 years, and -3.08% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Anthem Biosciences?
P/E ratio of and PB ratio of Anthem Biosciences are 67.96 and 12.74 on Jan 13, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse